Atorgar-CV

Atorgar-CV is a fixed-dose combination pharmaceutical product developed and manufactured by Apgar Pharmaceuticals for the management of cardiovascular diseases. It consists of two primary active ingredients: atorvastatin and clopidogrel. Atorvastatin is a lipid-lowering agent belonging to the statin class, which inhibits HMG-CoA reductase to reduce cholesterol biosynthesis and lower LDL levels. Clopidogrel is a thienopyridine-class antiplatelet medication that irreversibly inhibits platelet aggregation by targeting the P2Y12 receptor. This combination is typically utilized in patients at high risk of atherosclerotic events, such as myocardial infarction or stroke, who require concurrent management of hypercholesterolemia and platelet-mediated thrombotic risk. As a generic product, it is marketed in various strengths, such as Atorgar-cv 40, which denotes the dosage of the statin component.

Brand names

Atorgar-CVAtorgar-cv 40Atorgar-cv40Atorgar-cv-40

Other names

atorvastatin + clopidogrel